This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Lorraine G. Katz and a Microbial Bioconversion Process
Introduction
Lorraine G. Katz is an inventor associated with Merck & Co., Inc., and is listed in connection with one patent. Her work includes a microbial bioconversion process for producing a trans-hydroxy sulfone intermediate used in the development of topical carbonic anhydrase inhibitors.
Latest Patents
Katz is associated with the patent “Bioconversion Process for the Synthesis of Transhydroxy Sulfone.” The disclosed process uses the microorganisms *Rhodotorula rubra* or *Rhodotorula piliminae* to produce a trans-hydroxy sulfone with a diastereomeric excess greater than 95%. The intermediate is a precursor to topical carbonic anhydrase inhibitors, which are used in treating glaucoma and ocular hypertension. Katz is credited with 1 patent.
Career Highlights
Katz’s listed patent reflects work in microbial bioconversion and pharmaceutical intermediate synthesis. The invention describes a method for producing a compound relevant to potential treatments for eye conditions.
Collaborations
Katz’s listed coworkers include Steven A. King and Michel M. Chartrain. The patent is associated with Merck & Co., Inc.
Conclusion
Lorraine G. Katz’s patent contribution centers on a microbial process for synthesizing a high-purity trans-hydroxy sulfone intermediate with relevance to glaucoma and ocular hypertension treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile